🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center, randomized, double-blind, placebo-controlled study ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09
Trial ID
NCT07159243
Treatments Being Tested
The purpose of this study is to assess the relative potency of multiple ora...
Status
Completed
Location
New Orleans Center for Clinical Research
Start Date
2015-06-01
Trial ID
NCT02475317
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled study of single and ...
Status
Completed
Location
Clinilabs, Inc.
Start Date
2014-11
Trial ID
NCT02248818
The purpose of this study was to determine the safety and efficacy of TAK-5...
Status
Terminated
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00762684
This randomized, blind, parallel-group trial will evaluate the efficacy and...
Status
Unknown
Location
Fundación Oftalmológica de Santander - Clínica Ardila Lulle (FOSCAL)
Start Date
2015-08
Trial ID
NCT02369978
Treatments Being Tested
The purpose of this study is to assess the weight loss effect of lorcaserin...
Status
Completed
Location
Arena Pharmaceuticals, Inc.
Start Date
2007-12
Trial ID
NCT00603291
Treatments Being Tested
The primary objective is to provide dose-ranging data for 4 dose regimens o...
Status
Completed
Location
Total Skin and Beauty Dermatology Center, PC
Start Date
2019-07-31
Trial ID
NCT04015518
Treatments Being Tested
To evaluate the efficacy and safety of a Spirulina-derived product in preve...
Status
Not Yet Recruiting
Location
West China Hospital, Sichuan University
Start Date
2026-01-12
Trial ID
NCT07324018
Treatments Being Tested
This study is a single center, randomized, double-blind, placebo-controlled...
Status
Unknown
Location
Jinan Central Hospital
Start Date
2024-05-28
Trial ID
NCT06412185
The first phase of this study will be a parallel, 12-week treatment, Phase ...
Status
Completed
Location
Investigational Site Number : 0320006
Start Date
2021-11-24
Trial ID
NCT05107115
Treatments Being Tested